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Abstract: Self-assembly has fascinated many scientists over the past few decades. Rapid advances and widespread inter-
est in the study of this subject has led to the synthesis of an ever-increasing number of elegant and intricate functional 
structures with sizes that approach nano- and mesoscopic dimensions. Today, it has grown into a mature field of modern 
science whose interfaces with many disciplines have provided invaluable opportunities for crossing boundaries for scien-
tists seeking to design novel molecular materials exhibiting unusual properties, and for researchers investigating the struc-
ture and function of biomolecules. Consequently, self-assembly transcends the traditional divisional boundaries of science 
and represents a highly interdisciplinary field including nanotechnology and nanomedicine. Basically, self-assembly fo-
cuses on a wide range of discrete molecules or molecular assemblies and uses physical transformations to achieve its 
goals. In this Review, we present a comprehensive overview of the advances in the field of drug self-assembly and discuss 
in detail the synthesis, self-assembly behavior, and physical properties as well as applications. We refer the reader to past 
reviews dealing with colloidal molecules and colloidal self-assembly. In the first part, we will discuss, compare, and link 
the various bioinformatic procedures: Molecular Dynamics and Quantitative Structure Activity Relationship. The second 
section deals with the self-assembly behavior in more detail, in which we focus on several experimental techniques, se-
lected according to the depth of knowledge obtained. The last part will review the advances in drug-protein assembly. Na-
ture provides many examples of proteins that form their substrate binding sites by bringing together the component pieces 
in a process of self-assembly. We will focus in the understanding of physical properties and applications developing 
thereof. 
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1. INTRODUCTION 
Molecular self-assembly is the process through which 
single molecules arrange themselves spontaneously into dif-
ferent structures [1]. One of the most ubiquitous self-
assembly processes in physical chemistry is the hierarchical 
organization of amphiphile molecules into a huge variety of 
patterns as micelles, rods or liposomes among others [2]. 
Amphiphilic molecules constitute an important class of 
chemicals with a lot of applications in chemical process, 
pharmaceuticals or in food technology industries. On the 
other hand, they not only are highly interesting from a phys-
icochemical viewpoint but also are fundamental to life and 
living bodies: it is no exaggeration to say that all living 
things are made up of colloids comprising a wide variety of 
amphiphiles[3]. Such property has recently been employed 
to design and fabricate for a wide range of biotechnological 
applications because of their relatively simple structures and 
easy scale up commercial productions[4]. Some drugs ex-
hibit the same behaviour that traditional surfactants, they 
tend to self-aggregate, usually in a small aggregation num-
ber, when dispersed in aqueous solution in a surfactant like 
manner[5]. Although drug aggregates normally form at con-
centrations well above the concentration of the drug 
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appearing in body systems, micelles may be present in the 
pharmaceutical formulation to overcome different challenges 
including poor bioavailability, stability, side effects or 
plasma fluctuations of drugs. Also, it is of great interest the 
correlation between aggregation characteristics and the clini-
cal potency of antibiotics. The reason is that to obtain an 
optimal effect, the antibiotic must be administered at a low 
enough concentration at which aggregation is negligible. 
However, accidental accumulation at certain sites in the or-
ganism can possibly give rise to the formation of aggregates 
that do not pass through membranes; consequently, the anti-
biotics do not execute their therapeutic action. The associa-
tion of drugs has been examined by several workers finding 
a change in the slope of some physicochemical properties of 
these drugs in aqueous solutions which are indicative of a 
self aggregation. This discontinuity is identified with the 
critical micelle concentration and the shape and size of these 
aggregates depend mainly on the surfactant structure, ionic 
strength, and temperature and so on. When the drugs are 
delivered through hydrogels or micelle drug carriers, the 
diffusion and release rates of the drug molecules may be 
affected. Also, the free energies for the micellization of the 
surface-active drug molecules in solution are of the same 
magnitude as the free energy for absorption of drug mole-
cules to the carrier matrix. Hence, the hydrophobic moieties 
of the drug interact and tend to stabilize a cluster-like struc-
ture at the matrix of the carriers, which means that coopera-
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tive binding phenomenon has the same energetics as the mi-
cellization. Thus, surface activity of the drugs can predict 
their ability to cross the blood–brain barrier and can be quan-
tified by critical micelle concentration and surface area re-
quirement of the drug at the air/ water interface. Identifica-
tion of these properties will be leading to the molecular as-
sembly and the transport kinetics of the drug component [6]. 
The first studies on the aggregation characteristics of 
penicillins concern to penicillin G and correspond to work 
performed by Hauser et al. [7] at the Massachusetts Institute 
of Technology who by surface tension measurements noted 
that both penicillin and streptomycin salts, in the aqueous 
solution in which they are most commonly used for parental 
infections, are present in the form of colloidal micelles. This 
work was contradicted by Kumler and Alpen [8] who proved 
that this penicillin behaves as true solution and not as colloi-
dal electrolytes. A year later, McBain et al. publish an article 
[9] in which show that penicillin G aggregates in concen-
trated solution but at a critical concentration that it is of little 
biological interest. Studies of Hauser and Marlowe [7] and 
Hocking [10] set up the relationship between the activity of 
penicillin and their stage of aggregation. The work of Few 
and Schulman [11] analyzes the influence of the pH on the 
association of penicillin G. Ong and Kostenbauder report in 
their study [12] that micellar penicillin G is 2.5 times more 
stable than non micellar solution under the conditions of 
constant pH and ionic strength. The results of Funasaki et al. 
[13] permitted to know the mechanism of self-association of 
penicillin V (stepwise whithout any cmc) and establish the 
relationship between the self-association of penicillin V and 
penicillin G and the effect on the bacterial activity. Thakkar 
and Wilham [14] using NMR techniques confirms that peni-
cillin G ions aggregate in aqueous solution though hydro-
phobic interactions. Attwood and Argawal [15] has reported 
the micellar properties of several synthetic penicillins (in-
cluding flucloxacillin and cloxacillin) both in water and in 
the presence of 0.15 M NaCl. Amore recent study focused on 
the binary mixed system of betablocker with different lipo-
philicity [5]. Also the formation of monolayer of bile salts 
have been reported [16]. Recently, it was proposed the idea 
of combining two drugs forming a self-assembled system 
which display the drug function as well as serve as a vector 
[17]. 
On the other hand, the self-association of surface active 
drugs of quite different chemical structure has been widely 
reported [18]. Many of these drugs contain aromatic nuclei 
or are peptide nature. Examples of studied drugs are phe-
nothiazine [19] and benzodiazepine [20] tranquiliziers, anal-
gesics [21], peptide [22], antibiotics [23], tricyclic antide-
pressants [24], antihistamines [25], anticholinergics [26], -
blockers [5, 27], local anesthetics [28], non-steroidal anti-
inflammatory drugs [29], anticancer drugs [30]. Some of 
these structures can be observed in Fig. (1). 
On the other hand, reducing costs in terms of time and 
material resources with computational methods have become 
a promising goal in Medicinal and Pharmaceutical Chemis-
try. There many computational techniques that can be used 
in this sense, to cite a few: Molecular Dynamic simulations 
[31], Monte Carlo methods, Docking and/or Quantitative 
Structure-Property Relationships (QSAR). In any case, al-
most all of these methods focus on few fundamental aspects 
including: type methods to quantify the molecular structure, 
type (2) methods to link the structure with the biological 
activity, and mathematical functions to describe the interac-
tions and energies of the molecules.  
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Fig. (1). Chemical structure of some amphiphilic drugs. 
 
For this reasons, this review is organized as follows: 
there will be a short introduction on the more popular bioin-
formatic approaches including working principles, discus-
sion of the specific approaches, applications, and papers that 
are mainly based on it. Then we have chosen some studies 
based on the experimental approach. Here, we include dif-
ferent works based on most popular and accessible tech-
niques over the world and their interest in biotechnology and 
biomedical areas. 
2. MOLECULAR DYNAMIC STUDIES 
With recent increases in computing power, computer 
simulations have become indispensable tools. Molecular 
dynamic [31] simulations are probably the most popular ap-
proximation. There are two main families of MD methods, 
which can be distinguished according to the model chosen to 
represent a physical system. In the ‘classical’ mechanics 
approach to MD simulations molecules are treated as classi-
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cal objects, resembling very much the ‘ball and stick’ model. 
Atoms correspond to soft balls and elastic sticks correspond 
to bonds. The laws of classical mechanics define the dynam-
ics of the system. The ‘quantum’ or ‘first-principles’ MD 
simulations take explicitly into account the quantum nature 
of the chemical bond. The electron density function for the 
valence electrons that determine bonding in the system is 
computed using quantum equations, whereas the dynamics 
of ions (nuclei with their inner electrons) is followed classi-
cally [32]. The overall goals of classical MD retain their 
original essence (chemical bonds are springs, the electron 
density is places only at the nucleus and is constant, atoms 
are soft balls) and remain focused on the predictive ability of 
the approach and its receptiveness to physical interpretation. 
In molecular dynamics, the forces between molecules are 
calculated explicitly and the motion of the molecules is cal-
culated by means of a numerical integration method on a 
computer, basically solving Newton`s equation of motion for 
the atoms of the system. The initial conditions are the posi-
tions of the atoms and their velocities. From the initial posi-
tions, velocities and forces, it is possible to calculate the po-
sitions and velocities of the atoms at a small time interval, 
time step (usually of the order of 1 femtosecond), later. The 
cycle has to be repeated many times in the course of a full 
simulation, usually for many thousands of time steps. The 
forces are almost always based on an empirical potential 
such as the Lennard-Jones potential, electrostatic. A great 
advantage of the molecular dynamics method, is that it ex-
plicitly describes the molecular system as a function of time, 
this means it can directly calculate time dependent phenom-
ena. The molecular dynamics method was first introduced by 
Alder and Wainwright in the 50's to study the interactions of 
hard spheres (atoms that interact through perfect collisions) 
[33]. One decade later, Rahman performed the first simula-
tion using a realistic potential for liquid argon [34]. At the 
turn of the 70’s the first protein simulations appeared. Most 
authors claim that the first publication correspond to the 
simulation of the bovine pancreatic trypsin inhibitor (BPTI) 
performed by McCammon, when he was a research fellow at 
Harvard collaborating with Martin Karplus [35]. The simu-
lated protein was the small bovine pancreatic trypsin inhibi-
tor (BPTI), with approximately 500 atoms, in vacuum, and 
the simulation time was only 9.2 ps. However, is it also pro-
posed the work of Levitt et al. [36]. The first simulation con-
cerning to macromolecule-ligand interactions was developed 
by Case et al. in 1979 [37]. Three years later Kuntz et al. 
marks the beginning of the problem of “docking” molecules 
to each other: DOCK [38]. Here arises the pharmaceutical 
computation industry. By the same time Sundaram et al. 
reported molecular dynamic simulation of the drug nore-
piniphrine, demonstrating the possible ways of superposing a 
phenyl ring of a tricyclic antidepressant on the phenyl ring of 
norepinephrine [39]. Jonsson et al. reported molecular dy-
namics simulations of a sodium octanoate micelle in aqueous 
solution which results agree perfectly with NMR measure-
ments [40]. In 1988 the first simulation of a protein in ex-
plicit water is carried [41]. In 1990 the GROMOS force field 
is applied in the simulation of the complexation between 
deoxyninucleoside and proflavin [42]. One year later, MD 
simulations of the protein-inhibitor (chicken dihydrofolate 
reductase-trimethoprim) complexes, and the evaluation of 
potential energy interactions between inhibitor and protein, 
were evaluated for their ability to predict trends similar to 
those found for the thermodynamic simulations [43]. Next 
year, Heimstad et al. reveals the molecular structure, electro-
static potentials and dynamics of imipramine, chlorimi-
pramine, amitriptyline and nortriptyline, using the AMBER 
all atom force field [44]. In 2001 Kim et al. revealed that the 
size of chitosan self-aggregates varied in the range. of 130-
300 run in diameter, and their structures were found to de-
pend strongly on the molecular weight of chitosan ranging 
from 5 to 200 kDa [45]. Meanwhile, in other interesting 
work MD was employed to elucidate the molecular details of 
the process of fusion for small lipid vesicles. The simulations 
are based on a coarse grained (CG) lipid model that accu-
rately represents the lamellar state of a variety of phosphol-
ipids and enables us to observe intermediate stages during 
fusion at near atomic detail [46]. The review of Alonso et al. 
in 2006, focusing on applications and protocols of recent 
studies where docking calculations and molecular dynamics 
[31] simulations were combined to dock small molecules 
into protein receptors, is also remarkable. Recently, the MD 
simulations of the drug benzothiazole were performed to 
characterize the structure and dynamic behavior of the corre-
sponding aggregates at several concentrations of the drug 
[30]. Also the structure and properties of the structures spon-
taneously formed within aqueous mixtures of the hydrogen-
ated/fluorinated catanionic surfactant cetyltrimetylammo-
nium perfluorooctanoate in the absence of counterions as a 
function of its concentration were investigated by computa-
tional study at room temperature [2b]. 
3. QUANTITATIVE STRUCTURE ACTIVITY RELA-
TIONSHIP (QSAR) STUDIES 
It has been nearly 40 years since the quantitative struc-
ture-activity relationship (QSAR) paradigm first found its 
way into the practice of agrochemistry, pharmaceutical 
chemistry, toxicology, and eventually most facets of chemis-
try. Its staying power may be attributed to the strength of its 
initial postulate that activity was a function of structure as 
described by electronic attributes, hydrophobicity, and steric 
properties as well as the rapid and extensive development in 
methodologies and computational techniques that have en-
sued to delineate and refine the many variables and ap-
proaches that define the paradigm [47]. QSAR studies can 
reduce the costly failures of drug candidates in clinical trials 
by filtering the combinatorial libraries. Virtual filtering can 
eliminate compounds with predicted toxic of poor pharma-
cokinetic properties early in the pipeline. The chemoinfor-
matic methods used in building QSAR models can be di-
vided into three groups, i.e., extracting descriptors from mo-
lecular structure, choosing those informative in the context 
of the analyzed activity, and, finally, using the values of the 
descriptors as independent variables to define a mapping that 
correlates them with the activity in question [48] 
In 1996 Huibers et al. [49] propose a general three-
parameter structure -property relationship was developed for 
a diverse set of 77 nonionic surfactants, employing topologi-
cal descriptors calculated for the hydrophobic fragment of 
the surfactant molecule. The three descriptors represent con-
tributions from the size of the hydrophobic group, the size of 
the hydrophilic group, and the structural complexity of the 
hydrophobic group. They found that the cmc can be pre-
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dicted for a diverse set of nonionic surfactants using the 
equation  
log
10
cmc =  1.80 ± 0.16( )  0.567 ± 0.009( )c  KHO +
1.054 ± 0.048( )c  AIC2 + 7.5 ±1.0( )RNNO
 
The Kier & Hall index of 0 order for the hydrophobic 
fragment (c-KH0) represents the size of the hydrophobic 
fragment and contains group contributions from all non-
hydrogen atoms in the fragment. The average information 
content of order 2 for the hydrophobic fragment (c-AIC2) 
represents the complexity of the hydrophobic fragment. The 
final descriptor, the relative number of nitrogen and oxygen 
atoms (RNNO), represents the size of the hydrophilic frag-
ment.  
The aggregation properties of different amphiphilic an-
timicrobially active 2,2'-bipyridyl monoammonium salts 
were studied by means of QSAR, the authors discovered that 
from quantitative dependencies between lipophilicity (ex-
pressed by means critical concentration of micelle forma-
tion), structure (length of alkyl chain) and antimicrobial ac-
tivity (minimum inhibition concentration) that the maximum 
of activity is achieved with compounds of chain length m = 
13 to 16 [50]. 
Jalali-Heravi et al. [51] related the cmc of a set of 51 al-
kylpoyoxiethylene glycol ethers and alkylphenol ethers to 
topological, electronic and molecular structure parameters. 
Topological descriptors include Winer number, Tandic and 
Balaban indexes. Geometric descriptors include van der 
Waals volume of the molecule, maximum distance between 
the atoms in the molecule, surface area of the head and tail of 
the molecules. Electronic descriptors consist of heat of for-
mation and dipole moments of the molecules. From the ob-
tained results it was concluded that geometric parameter and 
van der Waals interactions play a major role in self-
aggregation of nonionic amphiphiles. 
The critical micelle concentration (cmc) values of a 49-
surfactant dataset derived from lactic, malic, and tartaric 
acids and from gluconolactone were subjected to Quantita-
tive Structure Property Relationship (QSPR) studies [52]. 
The model obtained takes into account seven descriptors. 
Five of them are topological and depend on the two-
dimensional structure of surfactants: Balaban index (JX), 
First kappa shape index (Kappa-3), Kier molecular flexibility 
index (PHI), second-order atomic connectivity index (CHI-
2), and Wiener index. Authors also identified the octanol–
water partition coefficient and the dipole moment as suitable 
measures of the cmc. Finally, the model used was as follows: 
 
log
10
cmc = 5.868 +1.175 JX  0.364 Kappa –
3 0.166 PHI  0.482CHI – 2 + 0.00128 Wiener 3  +
+ 0.171Dipole  mag + 0.203log P
 
In 2006, the Katritzky et al. [53] investigate a data set of 
119 diverse anionic surfactants to relate the logarithm of 
critical micelle concentration (cmc) to the molecular struc-
ture using Comprehensive Descriptors for Structural and 
Statistical Analysis (CODESSA Pro) software. The regres-
sion equation obtained contained variables that include fea-
tures of both hydrophobic and hydrophilic fragments of the 
surfactant:  
 
log
10
cmc = 1.89 ± 0.11( )  0.314 ± 0.010( ) t
sumKier & Hall index(0th order) 
 0.034 ± 0.003( ) total dipole of the molecule 
 1.45 ± 0.18( )h  sum  relative number of carbon atoms
 
In this equation the t-sum-Kier & Hall index of 0th order 
is the sum of the Kier & Hall index of zeroth order over all 
hydrophobic tails; the total dipole of the molecule is the 
AM1 calculated total dipole moment of the molecule; and 
the h-sum relative number of carbon atoms is the sum of the 
relative number of carbon atoms over all hydrophilic heads. 
A large number of molecular descriptors were explored in 
the initial descriptor pool, but the cmc was proved to be ap-
propriately modeled by the use of fragment descriptors de-
fined for the hydrophobic and hydrophilic domain of the 
molecule. 
In other interesting work, the developed QSARs provide 
insight into the mechanism of cytotoxic action of antimicro-
bial peptides. In a subsequent blind test, the QSAR correctly 
ranked four of five protegrin analogues newly synthesized 
and tested for toxicity [54]. 
Later, Katritzy et al. [55] developed Linear and nonlinear 
predictive models for 50 ammonium and quaternary pyridi-
nium cationic surfactants for both the first and second criti-
cal micelle concentrations. For the first cmc they found five 
descriptors. The descriptors were classified as follows: topo-
logical—Complementary Information Content (order 0) 
(D1), Average Information Content (order 0) (D3) and Wie-
ner index (D4), charge-related FPSA-3 Fractional PPSA 
(PPSA-3/TMSA) [Semi-MO PC] (D2), and quantum chemi-
cal—minimum electron–nuclear attraction for a C–N bond 
(D5). The significance of these descriptors of the model ac-
cording to t-test criterion was: D1 >D2 >D4 >D3 >D5. The 
experimental data points available for the second CMC re-
sulted in a model including just three descriptors. The most 
significant descriptor in the three-parameter model is the 
surface weighted charged partial positive surface area 
WPSA-3 Weighted PPSA(PPSA2*TMSA/1000)[Semi MO 
PC]. The WPSA-3 Weighted PPSA (PPSA-
3*TMSA)/1000[Semi-MO PC] is a fragment descriptor cal-
culated for the hydrophobic domain. The second one, the 
minimum exchange energy for a C–C bond descriptor is de-
fined for the hydrophilic domain of the surfactant molecule. 
This energy reflects the change in the Fermi correlation en-
ergy between the two electrons localized on C atoms and 
describes the conformational changes in the hydrophobic 
heads of the surfactant that play an important role in the ag-
gregation process. The last descriptor, the relative positive 
charge (QMPOS/QTPLUS)[Semi MO PC] is defined for the 
hydrophobic domain of the surfactant. The charge distribu-
tion in the surfactant molecule plays an important role in the 
aggregation of cationic surfactants. This descriptor has a 
large negative influence in the equation that is in accord with 
previous quantum chemical calculations that states that CMC 
increase when the surfactant tail gains positive charge, re-
spectively, the solubility of the molecule increase. 
MARCH-INSIDE (Markov Chain Invariants for Net-
works Simulation and Design) is a well-known type method 
for QSAR analysis. Recently, González-Díaz et al. [56] have 
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combined MI with ANNs (Artificial Neural Networks) in 
order to seek QSAR models. The name of this strategy is 
MIANN (MARCH-INSIDE & ANN models). The MARCH-
INSIDE approach [57] is based on the calculation of the dif-
ferent physicochemical molecular properties as an average of 
atomic properties (wj). For instance, it is possible to derive 
average estimations from molecular descriptors or local indi-
ces such as electronegativity values
 k(G) [58]. 
k G( ) = pk  j( )   j
jG
  

k
G( ) =  k p j G( )
jR
n
  log k p j G( ) 	  
 

k
G( ) = k pij G( )
i= jR
n
  
In this case, wj = j, the atomic electronegativity. It is 
possible to consider isolated atoms (k = 0) in a first estima-
tion of the molecular properties 
0(G), 0(G), or 0(G). In this 
case, the probabilities 
0
p(j) are determined without consider-
ing the formation of chemical bonds (simple additive 
scheme). However, it is possible to consider the gradual ef-
fects of the neighboring atoms at different distances in the 
molecular backbone. In order to reach this goal, the method 
uses an MCM, which determines the absolute probabilities 
pk(wj) with which the atoms placed at different distances k 
affect the contribution of the atom j to the molecular prop-
erty in question. In that work Ref humberto [56] authors ob-
tained by the first time a linear model able to predict the 
probability which with the compound (i-th) presents an ex-
perimental value of the property (j-th) higher than the aver-
age value of this property for this data set. The best model 
found using LDA was the following: 
S
i
Z
ij
> 0( ) = 3,91375+0,011557· eCsalt (molL
1 )  0,012303 T K( )
j
+ 0,244894  5 anion( )
i
 0,047320  5 cation( )
i
+1,919078 
5
 anions
j( ) + 3,436077 
5
 cations( )
j
n = 1085  2 = 221,2429 p  2( ) < 0.01
 
In this equation, Sij(Zij > 0) is a real-valued score (output 
of the linear model) that can be used to discriminate between 
surfactans with high probability p(Zij > 0) of showing a high 
Zij > 0 and others with high probability p(Zij  0) of present-
ing a Zij  0. Considering that Zij is an standardization coef-
ficient used to scale the values of the different properties to a 
single adimensional scale. We calculated this parameter as 
follow: Zij = (Yij - <Y>j)/SDj. Where, Yij is the value of the j-
th property of the i-th surfactant; <Y>j is the average value of 
his property in the data set and SDj the standard deviation. 
These parameters allowed us to classify the surfactants as 
“active” => C = 1 => Zij > 0 => Yij > <Y>j or “non-active” 
=> C = -1 => Zij  0 => Yij  <Y>j. It means, surfactants with 
a higher or lower-than-the-average value of the observed 
property j-th. The independent terms of the equation are: Csalt 
is the concentration of the salt in the solvent used;  is the 
average electronegativity of the surfactant for the anion or 
cation part; and ‹› are the average value of  for those sur-
factants with Zij > 0. This terms were calculated using the 
software MARCH-INSIDE. In addition, n is the number of 
cases used to train the model and 2 is Chi-square statistics 
with a given p-lvel = p(2). They used this linear model to 
predict satisfactorily the self-aggregation behavior of imi-
pramine hydrochloride in other experimental conditions dif-
ferent from those used in the previous experiments.  
4. SELF-AGGREGATION IN DRUG SYSTEMS 
The solubility of amphiphilic drugs in water is limited 
and produce a local ordering of the water molecules that sur-
round the hydrophobic moiety, that is, the hydrated head 
groups can take part in the H-bonding structure of the water 
producing the formation of micelles or other type of aggre-
gates. In addition, this spontaneous process is governed by 
the hydrophobic effect, which is related with the fact that the 
contact between water molecules and non-polar moieties of 
the drug molecule are minimized and the entropy of the sys-
tem is increased. Furthermore, there is an additional enthal-
pic term associated to the van der Waals clustering of the 
chains. Micelle formation is a cooperative process that oc-
curs over a narrow range of concentration and also over a 
critical temperature (called Krafft point), where the transition 
from the monomeric solution to a solution containing both 
monomers and micelles takes place. For that reason, it is 
necessary to define a concentration within this narrow range 
as critical micelle concentration (cmc) that is considered the 
saturation concentration for monomers. Furthermore, it is 
worth mentioning the strong dependence of the cmc on the 
chemical structure of the drug, the temperature and also on 
the presence of different cosolutes such as electrolytes or 
alcohols. A successive rise of drug concentration leads to an 
increase in the number of micellar aggregates, prior to any 
growth of the aggregates.  
Micelles may be characterized by the aggregation num-
ber (Nagg), and the molecular length sets the maximum radius 
for the spherical micelle shape. According to these consid-
erations, a packing parameter P is defined as the ratio be-
tween the volume  of the hydrophobic moiety of the mole-
cule and the product of the area occupied by the head group 
(polar group) a with the length l of the hydrophobic moiety 
of the molecule: P= /al. The values of the packing parame-
ter give us an idea about the type of structure: spherical mi-
celles (P < 1/3), elongated micelles (P < 1/2), vesicles (P < 
1) and lamellae (P  1). Additional factors that affect the 
micelle shape are the optimal head group area, the volume 
and length of the hydropobic moiety. The net aggregation of 
an ionic micelle is found to be less than the degree of micel-
lar aggregation. This indicates that large fractions of counte-
rions remain associated with the micelle. These counterions 
form the Stern layer at the micellar surface. In ionic micelles, 
the Stern layer, which resembles a concentrated electrolyte 
solution, consist of bound ionic surfactant head groups, 
counterions and water molecules. The water is present as 
both free molecules and water of hydration. The layer just 
beyond the Stern layer is a diffuse layer, known as the Gouy-
Champman layer, extending outward to several hundred ang-
stroms.  
4.1. Thermodynamics of Self-Aggregation 
Thermodynamic costs indicate whether processes are 
likely to occur and are conveniently quantified in terms of a 
free energy G. In the context of solvating a molecule, G is 
the reversible work for the solvent to reorganize and solvate 
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the solute. The thermodynamics of micellization is based on 
the Gibbs-Helmholtz equation: Gm = Hm - TSm, where 
Hm and Sm are the enthalpic and entropic changes incurred 
during solvation. The enthalpic part is a measure of the aver-
age potential energy of interaction between molecules, and 
the entropic part is a measure of the order or intermolecular 
correlations. The free energy of a process involving signifi-
cant changes in the number of molecular interactions, such 
as the breaking of hydrogen bonds to form a liquid-vapour 
interface, will be dominated by its enthalpic component [59].  
A process that requires specific spatial organization of 
hydrogen bonding patterns will have an important entropic 
component. At room temperature, for instance, the entropic 
cost of hydrating small hydrophobic species is dominant, as 
manifested by G increasing with increasing temperature. 
With a sufficient increase in temperature, however, the ex-
tent of hydrogen bonding between water molecules dimin-
ishes, and maintaining hydrogen bonds becomes less impor-
tant. In fact, whereas the entropy change associated with the 
hydration of a small alkane at room temperature is negative 
(and reasonably large in magnitude), it becomes positive 
near the boiling temperature of water [60]. 
Aggregates or micelles are dynamic species; in fact there 
is a constant, rapid interchange (typically on a microsecond 
timescale) of molecules between the aggregate and the solu-
tion pseudo-phases. This constant formation-dissociation 
process relies on a subtle balance of interactions. These in-
teractions come from contacts between: hydrocarbon chain-
water, hydrocarbon-hydrocarbon chains, head group-head 
group, and from salvation of the head group. There, the net 
free energy change upon micellization, Gm, can be written 
as: 
 
G
m
= G(HC) + G(contact) + G( packing) + G(HG)  
where G(HC) is the free energy associated with trans-
ferring hydrocarbon chains out of a water and into the inte-
rior of the micelle; G(contact) is the free energy attributed 
to solvent-hydrocarbon contacts in the micelle. G(packing) 
is a positive contribution associated with confining the hy-
drocarbon chain to the micelle core; and G(HG) is a posi-
tive contribution associated with head group interaction, in-
cluding electrostatic as well as head group conformation 
effects. Aggregation of drug molecules results from the ten-
dency of the hydrophobic groups to minimize contacts with 
water by forming oily microdomains with the solvent. There, 
interactions among non charged moieties are maximized, 
while hydrophilic head groups remain surrounded by water. 
The predominant effect of the drug molecule is to increase 
the degree of structure in the immediately surrounding water. 
This is one of the main features of the hydrophobic effect, 
which was studied in detail by Tanford to account the very 
light solubility of hydrocarbons in water [61]. During the 
micellar aggregation the reverse process occurs, that is, as 
lyophobic residues aggregate, the highly structured water 
around each chain collapses back to ordinary bulk water 
thereby accounting for the apparent large overall gain in en-
tropy, Sm. 
The mechanism of micelle clustering process from sur-
factant monomers, S, can be described by a series of step-
wise equilibrium 
 
S + S
K
2
S
2
+ S
K
3
S
3
+…
K
n
S
n
+ S  
 where the thermodynamic parameters for the aggregation 
process can be expressed in terms of equilibrium constants 
Kn. However, each Kn, cannot be measured individually, so 
different approaches have been proposed to model the ener-
getic of the process of self-assembly. Although not totally 
accurate, two simple models are generally encountered: the 
mass action model and the phase separation model. In the 
mass action model, with the size range of spherical micelles 
around the cmc being very limited, it is assumed that only 
one of Kn value is dominant, and micelles and monomeric 
species are considered to be in chemical equilibrium: 
 
nS  S
n
 
 where n is the number of drug molecules , S, associating 
to form a micelle [62], that is, the aggregation number. 
Considering only univalent counterions, it is possible to 
describe for example ionic surfactants as M
+
S
-
 and assume 
these are completely dissociated into M
+
 and S
-
. The self-
assembly of low molecular weight anionic surfactant mole-
cules to form micelles may be represented by 
 
nS
 + mM +  S
n

M
m
+( )
z
 
 where n is the degree of aggregation and z is the net 
charge of the micelle which is given by z = n - m. The 
charge of the micelle may also be expressed as the fraction 
ionized,  = (n - m)/n. 
The chemical equilibrium between monomeric drug ions 
and micelles is assumed with a corresponding equilibrium 
constant, Kn, and in mass action approach is given by: 
 
K =
a
mic
 
a
S
 
n
a
M
 
m

 where the brackets indicate the activities of the indicated 
species. 
The equilibrium constant gives the standard free energy 
of micellization 
 
G0 = RT ln K = RT ln a
mic
 n ln a
S
 m ln a
M
( )  
The standard free energy per mole of drug evaluated at 
the cmc (aM  aS = acmc) becomes: 
 
G
mic
0 = RT 1+ m
n
( ) ln acmc  1
n
ln a
mic





  
 where m/n   represents the fraction of charges of mi-
cellized univalent drug ions neutralized by micelle-bound 
univalent counterions. Assuming that the aggregation num-
bers is large (> 100) we can do an approximation on the ex-
pression of Gºmic: 
 
G
mic
0  RT 1+ m
n
( ) ln acmc 
Considering that cmc occurs in dilute solutions, so activ-
ity may be replaced by the concentration of the drug at the 
cmc 
G
mic
0  RT 1+ m
n
( ) ln cmc  
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4.2. External Factors Affecting the Self-Aggregation 
The tendency toward aggregation process may be 
strongly affected by the structure of the drug, the counterion 
nature, the presence of additives or the change in tempera-
ture [19, 27d, 27g, 63]. The length of the hydrophobic moi-
ety is a major factor determining the cmc. As an example, 
for a homologous series of linear single chain surfactants, the 
cmc decreases logarithmically with carbon numbers. The 
relationship usually fits the Klevens equation [64]: log(cmc) 
= A-Bnc. Where A and B are constants for a particular ho-
mologous series and temperature, and nc is the number of 
carbon atoms in the chain. The constant A varies with the 
nature and number of hydrophilic groups.  
Variations in the hydrophilic head group affect the cmc. 
In general, drug containing ionic head group have a higher 
cmc than those containing nonionic head groups. This is due 
to electrostatic repulsion between the head groups of neigh-
boring molecules within the micelles. A polar group reduces 
the overall hydrophobicity of an apolar solute by an amount 
equivalent to several methylene groups: the hydration shells 
of polar groups overlap with those of methylene groups. Al-
ternatively, introduction of polar functionalities increases the 
solubility of apolar solutes since it reduces the necessity for 
creating a complete hydrophobic hydration shell. Generally, 
hydration of the polar group extends to the third carbon atom 
in the apolar moiety of drug molecules [27d, e, 65]. 
The counterion atmosphere surrounding the micelles 
leads to preferential counterion binding that affects the 
shape, size and interaction on the micelles. Ionic surfactants 
may form a variety of micellar structures depending on the 
nature of the counterion. The smaller and more hydrophilic 
counterions induce formation of spherical micelles. This is 
due to the weak binding of these counterions to the micelles 
which leads to an effective decrease of the electrostatic re-
pulsion between the drug head groups. Ionic drug with or-
ganic counterions form thread-like structures that result in 
viscoelastic behavior of the solution [66]. This effect is at-
tributed to the much stronger binding of the counterions to 
the micelles and even to intercalation between oppositely 
charges surfactant head groups. As a result, the electrostatic 
repulsion between the drug head groups is screened more 
effectively which reduces the curvature of the surfactant 
spherical aggregate and lead to formation of cylindrical mi-
celles. 
The presence of electrolytes causes a decrease in the cmc 
of most surfactants [27f, 67], that is, when ions are added to 
a micellar solution, can dehydrate the surfactant headgroups. 
This causes an increase of the structural packing parameter 
and as a consecuence, the cmc is reduced and the aggregate 
morphology changed. The effects are caused by destruction 
of the hydration layer of the drug, decreased electrostatic 
repulsions, and a increased counterion binding. The greatest 
effect is found for ionic drugs. The main effect of the salt is 
to partially screen the electrostatic repulsion between the 
head groups and so lower the cmc. 
4.3. Effect of Temperature 
The temperature dependence of the cmc of most ionic 
surfactants describes a U-shape curve, as it is shown in  
Fig. (2). This behavior is interpreted as a consequence of two 
opposing effects: the hydration of the head group and the 
structured water molecules surrounding the hydrophobic 
moiety. The increase in temperature produces a decrease in 
the hydration of the head group and an increase in the break-
down of the structured water molecules surrounding the hy-
drophobic part. The first favors micelle formation while the 
second does not. The first effect is dominant at lower tem-
peratures and the second at higher, so the minimum (T* and 
cmc*) represents the compensation of both effects. The sec-
ond effect becomes greater when the hydrophobic moiety 
length increases. The decrease in the minimum when the 
hydrophobicity increases is consistent with this argument. 
 
 
Fig. (2). Natural logarithm of the critical aggregation concentration 
as a function of temperature. The solid line corresponds to the fit of 
experimental data to the thermodynamic model proposed by Rodri-
guez et al.  
 
A first analysis of the relations between cmc and tem-
perature was developed by La Mesa [68]. He assumed that 
cmcmin and Tmin are reference values for the micellization, so 
it is possible to fit experimental data to the equation 
 
cmc
cmc *
1= 1 T
T *
 
 where  is an exponent whose numerical value is 1.74 ± 
0.03 without physical meaning. Although La Mesa used his 
model to forecast cmc values in a wide range of experimen-
tal conditions and with different compounds, it have some 
problems with some systems [69]. Later, Muller [70] de-
scribed the variation of cmc with temperature by means of 
the equation 
 
ln(cmc cmc *) = C
p
(1+ )R{ } 1 T *T + ln T *T( ){ }  
 where Cp is the heat capacity and  the degree of ioniza-
tion. Although in this equation variables with physical mean-
ing are introduced, the preliminary assumptions (Cp and  
constant with temperature) are quite severe.  
Kang et al. [71] proposed a simple modification of La 
Mesa´s equation, introducing a constant:  
 
cmc cmc *1= A 1 T T *
B
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These authors have also proposed an elegant description 
of the cmc as a function of temperature; however, it is possi-
ble that the excessive number of variables in their model has 
forced them to introduce too severe approximations. For 
example, the compensation temperature and the temperature 
at which entropy becomes zero have constant values for 
most surfactants, but it is possible to find references in the 
literature that show that these values depend on the molecule 
[72] and even depend on the electrolyte concentration [27e]. 
Assuming a linear behavior of enthalpy of aggregation with 
temperature, the slight dependence of  with temperature that 
in some cases could be assumed as a constant and taking into 
account the linear behavior of the enthalpy–entropy compen-
sation phenomena, the relation is as follows: 
ln x* = A+ BT +
C
T
 1
2  ( )n
ln 2n
2
2  ( )   ln
2

S
 
 where S is the valence of the surfactant ion and A, B and 
C are 
A =
C
P,m
0
2  ( )R
1+
T
S=0
T
C



	
< 0  
 
B =
C
P,m
0
2  ( )RT
C
> 0  
C =
C
P,m
0
T
H=0
2  ( )R
> 0  
 where, TH=0, TS=0 and TC are the temperature at Hºm = 0, 
Sºm = 0 and the compensation temperature, respectively. 
The logarithmic terms can be neglected because usually they 
are much lower than the first three terms. In the final equa-
tion,  and Cºp,m, and TH=0, TS=0 and TC are considered as 
constants. A known constant value can be TC, known as 
compensation temperature, and the same is assumed for all 
the ionic molecules. Furthermore,  can be used as a known 
constant and equal to  at T*. Using these parameters and 
taking TH=0, TS=0 and Cºp,m as free parameters, all the rele-
vant thermodynamic parameters of the aggregation process 
can be obtained 
Recently, Rodriguez et al. [73] improved Muller´s equa-
tion by assuming that the degree of ionization of the aggre-
gates increases linearly with temperature, = 0 + 1T, and 
the standard change in heat capacity varies linearly in the 
temperature range studied by means of the equation 
CP,m0 = CP,m0* + T  T *( )  
Thus, based on these assumptions they arrived at the fol-
lowing equation: 
ln xcmc = ln xcmc
* 1+ 1T *
1
2  
T *
T
 2  0  2
1T *
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
+
1
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0  2
1T *
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
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
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
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

+
+
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*
T
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T *
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
+

2  ( )R
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2T
+ T * ln
T
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
This equation relates entropy, enthalpy and heat capacity 
of aggregation with the corresponding Gibbs free energy as a 
function of temperature. The parameters in this equation are: 
T*, lnxcmc, Cº*p,m, , 0 and 1. At a minimum, Hºm and 
Sºm can be obtained from the following relations: 
 
H
m
0*
= RT
*2
1
ln x
cmc
*
 
 
S
m
0*
=
H
m
0*
T
*
2 +

0
 2

1
T
*



	
 
In some cases the temperature dependence of  is not 
evident and can be taken as a constant. An appropriate equa-
tion was recently used by González-Pérez et al. [74] 
ln x
cmc
= ln x
cmc
* +
C
P,m
0*
2  ( )R
1 T
*
T
 ln T
T
*

	



+

2  ( )R
T
*2  T 2
2T
+ T * ln
T
T
*

	



 
The parameters in this equation are: T*, lnxcmc, Cº*p,m, 
, , and in this case Hºm and Sºm remain as follows: 
 
H
m
0*
= 0  
 
S
m
0* = R ln x
cmc
*   2( )  
Another possibility can be developed by taking into ac-
count the linear dependence of b with temperature, letting 
Cº*p,m remain constant with temperature. This possibility 
was used recently by González-Pérez et al. [75]. The expres-
sion remains as follows: 
 
ln x
cmc
= ln x
cmc
*
1+ 
1
T
* 1
2  
T
*
T
 2 

0
 2

1
T
*

	



+
1
2  *
1+

0
 2

1
T
*

	



















+
+
C
P,m
0*
2  ( )R
1 T
*
T
 ln T
T
*

	



 
We report now the thermodynamic parameter of aggrega-
tion for several penicillins: sodium cloxacillin, sodium di-
cloxacillin, nafcillin sodium, penicillin V [23b], ampicillin 
sodium [23a], oxacillin sodium [76] and penicillin G [72]. 
First of all we have to divide these penicillins in two groups 
as a function of their present one or two stage self associa-
tion process. The first group will be constitute by cloxacillin, 
dicloxacillin and nafcillin, meanwhile penicillin G and V, 
ampicillin and oxacillin will be in the second one. In two 
stage self association process, an initial association occurring 
in dilute solution, leads to the formation of small aggregates 
which may then self associate to form larger aggregates at a 
second critical concentration, corresponding to the reported 
cmc. Obviously thermodynamic parameters will be calcu-
lated in every stage. The variation of the cmc with tempera-
ture for these penicillins can be fitted to any of the thermo-
dynamic models previously proposed. In all cases, the curve 
passes through a minimum around 300 K, except for am-
picillin at 295 K. Penicillins with two stage association have 
showed the same minimum for both stages. An interpretation 
of these variation has been suggested by Zielinsky [77] pos-
tulating the existence of two hydrations around the am-
phiphile molecule, one around the hydrophobic part and 
other around the polar headgroup. The increase in tempera-
ture decrease the hydration around the two parts, and the 
observed minimum on the cmc-temperature plot reflects the 
effect of rising temperature on a balance between a gradual 
dehydration of the hydrophobic part (this promotes micelli-
zation) and a partial dehydration of the hydrophilic part, 
leading to an increase in repulsion between polar head-
groups. The partial dehydration can spread to the surface of 
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micelles already formed. The variation of the equilibrium 
constant for the aggregation process with temperature was 
attributing only to the temperature coefficient of the cmc. 
The standard Gibbs energy change per mole of monomer for 
these penicilins are plotted in Figs. (3, 4 and 5). In Fig. (3) 
only the energies for penicillins with one stage of aggrega-
tion are plotted meanwhile in Fig. (4) and Fig. (5) we have 
plotted the energies for penicillins corresponding to the first 
and second stage of aggregation respectively.  
Table 1 shows the temperature dependence of the en-
thalpy and entropy of aggregation per mole for each self ag-
gregation. Standard Gibbs energy are of the same order for 
all these penicillin, taking into account that for penicillins 
with two critical points, the total Gibbs energy will be the 
sum of both stages. It is interesting to observe the Gibbs en-
ergies for ampicillin, oxacillin and penicillin G. In the first 
stage ampicillin shows the greatest values, however oxacillin 
will be the greater in the second. If we rescue the aggrega-
tion numbers obtained from light scattering. In the first stage 
we obtain two monomers for penicillin G and oxacillin 
meanwhile for ampicillin are three. In the second stage the 
number of aggregates that join themselves are two for am-
picillin, three for penicillin G and four for oxacillin, indicat-
ing that Gibbs energy reach the higher values for the greater 
aggregation numbers. Positive values of standard enthalpy 
are generally attributed to the release of structured water 
from the hydration layers around the hydrophobic parts of 
the molecule during the formation of aggregates. Such hy-
drophobic interactions become increasingly insignificant 
with the partial breakdown of the structure of water as the 
temperature is increased and the aggregation becomes pri-
marily an enthalpic process, the negative enthalpy values 
suggest the importance of the London-dispersion interaction 
as the major force for aggregation. For the second stage the 
slope of the enthalpy is lower for ampicillin and penicillin G, 
and thus in this case we have small aggregates which mini-
mize the contact surface of monomers with water, the hydro-
phobic interactions being less important. However oxacillin 
exhibits the opposite behavior, this event it could be attrib-
uted to high aggregation number in the second stage (related 
to the first). Standard entropy calculated from Gibbs energy 
and enthalpy for these penicillins decrease progressively 
with temperature showing that at temperatures below the 
critical concentration minimum the aggregation is driven 
solely by the positive Sºm. 
Another interesting feature arise if we correlate the en-
thalpic and entropic contributions to micellization Hºm ver-
sus Sºm. Thus, we obtain linear relationship, the so-called 
compensation phenomenon. Experimental data can be fitted 
to equation Hºm = Hº*m +TcSºm, where Tc is the compen-
sation temperature. Lumry and Rajender [78], Sugihara et al. 
[79] have interpreted this phenomenon as micelle formation 
being a desolvation process form a monomeric state to a mi-
cellar state and vice verse, i. e., in micelle formation the wa-
ter molecules surrounding amphiphilic molecules play a 
more important role that the surfactant molecules them-
selves. When hydrates ionic groups of amphiphiles are 
bound with surrounding water molecules, the process leads 
to an energetic stabilization (negative enthalpy change). At 
the same time, the motion of water molecules bound to ionic 
groups causes a decrease in entropy. In the process of mi-
celle formation (translation of hydrophobic groups from bulk 
to micelle), the entropy increase and a negative change in 
free energy takes place. The entalphy changes in conjunction 
with the entropy and switches its sign from negative to posi-
tive at a certain temperature, the compensation temperature. 
The interpretation most commonly accepted for Tc is that it 
simply reflects the cooperation of enthalpy with entropy for 
the systems studied under determined conditions. We can 
then state this value as characteristic for the micellization 
process of the penicillins and betablockers in water in the 
temperature range of 288.15 K to 313.15 K. The intercept 
correspond to the entropy change at a specific temperature, 
giving Hºm = 0. In this situation, the driving force of mi-
celle formation comes only from the entropy term, i. e., the 
standard Gibbs energy of micellization only has an entropy 
term. The temperature at which this takes place is the mini-
mum of the cmc-temperature plots. As it has been suggested, 
 
Fig. (3). Standard Giggs energy of aggregate formation per mol of 
monomer for: ()cloxacillin; ()dicloxacillin and () nafcillin. 
 
 
Fig. (4). Standard Giggs energy of first stage aggregate formation 
per mol of monomer for: (ampicillin; (oxacillin and (
penicillin. 
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it would be an index of the hydrophobic-hydrophilic bal-
ance[27e].  
 
 
Fig. (5). Standard Gibbs energy of second stage aggregate forma-
tion per mol of monomer for: (ampicillin; (oxacillin and 
(penicillinG 
 
5. COMPLEXATION WITH PROTEINS 
Molecular self-assembly is central to molecular medi-
cine, one of the most active trend in health area. Much of 
biotechnological, medical and drug delivery systems aims to 
predict their behavior on the basis of the set of molecules 
involved, mainly proteins and drugs. Understanding the in-
teractions between these molecules is therefore crucial to 
such efforts [80]. Understanding protein-drug interactions is 
central to drug design and the discovery of new medicines to 
benefit human health. Also, recent advances in nanotechnol-
ogy or hybrid nanomaterial have triggered the enthusiasm for 
these complexes [81]. The ability to identify small molecule 
ligands for any protein of interest has far-reaching implica-
tions, both for the elucidation of protein function and for the 
development of novel pharmaceuticals [82]. 
The interaction of a range of penicillins, nafcillin, clox-
acillin, dicloxacillin, and flucloxacillin with human serum 
albumin (HSA) in aqueous solution at pH 7.4 at 25 °C [83] 
have been investigated by means of zeta potential measure-
ments. The interest in the interactions of penicillins with 
HSA arises from reports of allergic reactions in some sub-
jects to penicillin and other -lactam antibiotics and to evi-
dence of haptenation of penicillin by conjugation with serum 
proteins, resulting in the formation of IgE antibodies. The 
interaction of penicillins with HSA arises both from the hy-
drophobic nature of the drugs and the presence of hydropho-
bic cavities in the protein structure [84]. The -potentials of 
HSA became more negative as the negatively charged peni-
cillins bind to it. The variations of -potential with drug con-
centration have been interpreted in terms of a modification 
of the theory of Ottewill and Watanabe (OW) to take into 
Table 1. Standard enthalpy ( Hm0  in kJ mol
-1
) and entropy ( Sm0  in kJ mol
-1
K
-1
) of micelle formation per mol in water at different 
temperatures (T in K). 
 Cloxacillin Dicloxacillin Nafcillin 
T Hm0  Sm0  Hm0  Sm0  Hm0  Sm0  
288.15 2.9 88 4.5 82 7.5 102 
293.15 1.2 82 2.2 75 3.7 89 
298.15 -0.5 76 -0.3 66 -0.3 75 
303.15 -2.4 70 -2.9 58 4.7 61 
308.15 -4.4 63 -5.7 49 -9.3 47 
313.15 -6.5 57 -8.8 40 -14.2 31 
 
Ampicillin Oxacillin Penicillin G 
 
First Second First Second First Second 
T Hm0  Sm0  Hm0  Sm0  Hm0  Sm0  Hm0  Sm0  Hm0  Sm0  Hm0  Sm0  
288.15 7.6 89.8 3.1 63 19.7 96 38.0 195 22.5 30 8.1 21 
293.15 3.4 76.1 1.3 57 12.0 70 23.9 146 13.6 22 5.5 19 
298.15 -2.5 55.6 -0.7 50 3.7 42 8.7 95 4.0 12 2.6 16 
303.15 -8.8 34.4 -2.8 43 -5.1 12 -7.5 42 -6.3 2 -0.5 14 
308.15 -15.6 12.0 -5.0 36 -14.5 -18 -24.7 -14 -17.2 -8 -3.7 10 
313.15 -22.7 -10.4 -7.3 28 -24.6 -50 -43.2 -74 -28.9 -20 -7.2 7 
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account the cooperativity of drug binding in terms of the Hill 
equation [85]. The Hill coefficients for the drugs were all 
greater than unity and diagnostic of positive cooperativity on 
binding [86]. The plots and the Gibbs energies per drug 
molecule bound as a function of the number of drug mole-
cules bound per protein molecule are closer to the experi-
mental values from equilibrium dialysis experiments than 
when the Langmuir isotherm is used. The modified OW the-
ory was consistent with the clustering of drug molecules on 
the polypeptide chain of the protein and a description of the 
resulting complexes in which the protein is covered in mi-
celle-like aggregates. In all studied systems the standard 
Gibbs energies of adsorption evaluated from the above equa-
tion have shown that Gibbs energies are large and negative at 
low values of drug concentration where binding to the high 
energy sites takes place, and become less negative as more 
drug molecules bind suggesting a saturation process [87]. As 
an example, calculated values of the number of adsorption 
sites and Gibbs energies of different drugs including: penicil-
lins [88,
,
89], betablockers [27c] or antidepressants [90]
,
onto 
human serum albumin can be consulted in Table 2. 
 
Table 2. Number of adsorption sites, N1, and standard gibbs 
energy of adsorption, Gads0 , of some drug onto hu-
man serum albumin. 
Drug N1 (m
-2
) Gads0  (kJ mol-1) 
Cloxacillin 8.341015 -7.7 
Dicloxacillin 2.371016 -10.2 
Nafcillin 1.091016 -7.7 
Propranolol 5.481015 -14.2 
Verapamil 4.091010 -7.8 
Amitriptyline 1.031017 -4.1 
Nortriptyline 9.11014 -7.9 
Imipramine 9.81015 -5.7 
Desipramine 6.51015 -5.8 
 
As an illustrative example, the adsorption of nafcillin on 
catalase at different pHs can be useful [91]. Obtained iso-
therms at pH 3.2 reveals an initially binding of the anionic 
nafcillin to cationic residues, followed by hydrophobic bind-
ing at the drug concentration approaching the critical micel-
lar concentration (cmc) of the drug. The isotherm passes 
through maxima. Such behavior has been attributed to the 
activity of long-chain ions going through a maximum in the 
vicinity of the cmc. At pH 7.4 and 10.0, specific binding to 
cationic sites is lost, and only hydrophobic binding occurs. 
The number of drug molecules per amino acid residue was 
0.37, 5.4, and 4.64 for pH 3.2, 7.4, and 10.0, respectively. 
The complexation of nafcillin, cloxacillin, dicloxacillin, 
and flucloxacillin, with human serum albumin (HSA) in 
aqueous solution, pH 7.4, has been also analyzed by equilib-
rium dialysis [92]. In this case, the binding process is largely 
non- specific. The binding isotherms for the drugs range up 
to values of 3000 for nafcillin and cloxacillin, 1200 for di-
cloxacillin, and 2000 for flucloxacillin. Human serum albu-
min consists of 585 amino acids18 so binding of 3000 drug 
molecules corresponds to approximately 5 drug molecules 
per amino acid residue; this suggests clustering of drug 
molecules along the polypeptide chain. Such a cluster size 
corresponds closely to the aggregation numbers of the drug 
micelles, which at an ionic strength of 0.1 M were found to 
be 5 (cloxacillin), 5 (dicloxacillin), and 4 (flucloxacillin). 
However, these data do not allow to draw any conclusions 
about the uniformity of binding along the polypeptide chain, 
although it is likely that binding is greater (and cluster size 
larger) around hydrophobic aminoacid residues and in hy-
drophobic cavities in the protein and less around hydrophilic 
residues [93]. On the other hand, binding strength as repre-
sented by the Gibbs energies of binding increases (becomes 
more negative) in the sequence dicloxacillin > nafcillin > 
flucloxacillin > cloxacillin, although the differences between 
the latter three are not large. The larger Gibbs energy of 
binding for the dichloro drug are related to a contribution 
from dipole interactions that may be greater than in the case 
of the monohalide drugs, cloxacillin and flucloxacillin. The 
nafcillin interaction is stronger than the monohalide interac-
tions because of a greater hydrophobic contribution arising 
from the naphthalene ring. 
UV difference spectroscopy have been utilized to study 
the interaction of the amphiphilic drug propranolol hydro-
chloride with human haemoglobin (HH) and human serum 
albumin (HSA) in aqueous solution at different pHs [27c, 
94]. Addition of propranolol results in the development of an 
absorption band in the region of 410 nm that is positive with 
respect to native HH, arising from the extended -electron 
system of the porphyrin ring. For the HSA/propranolol sys-
tems the main peaks were observed at 410, 413, and 417 nm 
for pHs 2.5, 4.9, and 8.0, respectively. The UV absorption of 
human serum albumin (HSA) increased smoothly with in-
crease of concentration of added propranolol hydrochloride 
at all pHs as a consequence of adsorption of the drug ions. In 
contrast, an abrupt change in these properties was observed 
for the human haemoglobin (HH)/propranolol system at a 
concentration of approximately 0.05 mol kg-1 at pH 2.5. 
This change has been attributed to a tetramer to dimer transi-
tion arising from the increase of concentration of drug which 
functions as an electrolyte. 
Fig. (6) shows static light scattering data for HSA in 
aqueous solutions containing between 0.015 and 0.15 molkg
-
1
 nafcillin [89]. In this treatment of the data nafcillin has 
been considered as an electrolyte, so the system is acting as a 
binary system formed by the protein complex as solute, and 
the nafcillin water as solvent. Molar masses, derived from 
the intercepts of Fig. (6) increased linearly with concentra-
tion of added drug. The molar mass obtained using the De-
bye equation for the HSA in pure water was 7.9104 g mol-1, 
which corresponds to an association number N = Mw/M0 
(where M0 is the molecular weight of the HSA, 6.641104 g 
mol
-1
) of 1.19 indicating only limited association. The aver-
age number of nafcillin molecules adsorbed onto the protein 
can be obtained from the difference between the molar mass 
of HSA (6.6104 g mol-1) and that of the complex, divided 
by the molar mass of nafcillin (454.5 g mol
-1
). The average 
number of nafcillin molecules adsorbed onto HSA derived 
by this method changes with nafcillin concentration from 
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171 (at 0.015 mol kg
-1
) to 1075 (at 0.15 mol kg
-1
). Based on 
these results it can be deduced that at small drug concentra-
tions, individual drug molecules bind to the protein which 
results in small changes in protein structure. On the other 
hand, drug molecules at higher concentrations aggregate to 
form micelle-like clusters along the unfolded polypeptide 
chains of the protein. HSA has exhibit the same pattern in 
the presence of other drugs such as cloxacillin, dicloxacillin 
[95] and verapamil [90]. This behavior has been studied not 
only by experimental techniques but also by a theoretical 
formalism based on the combination of the Brunauer–
Emmet–Teller multilayer adsorption model with an electro-
lytic adsorbate. The experimental binding processes are cor-
rectly predicted by this noncooperative binding model and it 
is demonstrated to be due to the ionic character of the drug. 
The effect of the hydrophobic interactions between drug 
monomers is also a matter of study, and it is proven that this 
number increases with increasing hydrophobic character of 
the drug molecule [96]. 
 
 
Fig. (6). Kc/R90, as a function of the human serum albumin concen-
tration in aqueous solutions of the drug nafcillin. 
 
The interaction potential between the protein/drug com-
plexes and their stability can be determined from the de-
pendence of diffusion coefficients on protein concentration. 
For this purpose, the DLVO theory can be refined or modi-
fied by including other terms in the potential V(x), the elec-
trostatic potential can be evaluated more accurately by using 
the nonlinear Poisson- Boltzmann equation or by other mod-
els. Finally, the physical meaning of the cutoff distance can 
be defined on the basis of ionic strength dependence. Fig. (7) 
shows the V(x)/kBT curves for the system HSA/propranolol, 
for a set of propranolol concentrations, showing the pre-
dominance of electrostatic repulsion at each concentration, 
which leads to a very stable dispersion. Increased adsorption 
with increasing propranolol concentration leads to screening 
of the electrostatic potential and the increasing importance of 
London-van der Waals attraction. Other typical values of A 
and q obtained for HSA in the presence of different drugs 
were: A = 0.4110-22 J and q = 2.2 uec (unit of electron 
charge) in the presence of propranolol [27c]; A = 4.1110-23 
J and q = 0.35 uec in the presence of nafcillin [89]; A = 
4.110-23 J and q = 1.13 uec in the presence of cloxacillin; A 
= 2.510-23 J and q = 1.01 uec in the presence of dicloxacil-
lin [88].  
 
Fig. (7). Plots of the pair interaction potential (V), between 
HSA/propranolol complexes, as a function of the reduced and nor-
malized distance (x) at the propranolol concentrations indicated in 
the graph. HSA concentration 0.125% w/v. 
 
Different thermodynamic and statistical mechanical ap- 
proaches to describing unfolding, stability and energy of  
proteins linked to a ligand have been discussed in literature  
[97]. Early studies have demonstrated the usefulness of  
Differential Scanning microcalorimetry (DSC) in under- 
standing the drug-resistance mechanism caused by muta- 
tions. When drugs bind to a protein, the energy of ligand  
binding adds incrementally to the protein`s stabilization en- 
ergy and the protein`s Tm is increased by an amount that is  
proportional to the ligand binding energy. Thermodynamic  
analysis of the Tm, or thermal shift, associated with ligand  
binding can be semiquantitatively related to ligand binding  
affinity, subject to reasonable assumptions regarding the  
ligand binding enthalpies of drug-like compounds [98]. En- 
teric-coated bovine serum albumin (BSA) nanospheres car- 
rying cyclodextrin complex were performed for indometha- 
cin delivery. The inclusion complex and the nanospheres  
were characterized by DSC analysis. The thermal behavior  
of albumin nanospheres showed no phenomena in the tem- 
perature interval. Albumin nanospheres carrying inclusion  
complex showed disappearance of the endothermal peak of  
indomethacin indicating the the strong drug interaction with  
albumin or albumin/betacyclodextrin carrier. The results  
showed that indomethacin solubility can be increased by  
complexation with protein/drug interaction with albumin  
nanospheres [99]. DSC studies on amorphous trehalose- 
water systems with embedded proteins (myoglobin,  
lysozyme, BSA, hemoglobin) were performed. From DSC  
upscans the thermodynamic properties of the matrix (glass  
transition) and the functional properties of the encapsulated  
protein (thermal denaturation) were calculated. At high hy- 
dration, the presence of the proteins increases the glass tran- 
sition temperature of the encapsulating matrix. An increase  
of the protein thermal stability is observed in the whole hy- 
dration range, a finding potentially of high biotechnological  
relevance [100]. 
DSC thermograms have allowed characterizing the proc-
esses involved in synthesis of the antibody-drug conjugate 
Trastuzumab-DM1 (a semysinthetic ansamaclolide) [101]. 
Self-Assembly Drugs: From Micelles to Nanomedicine Current Topics in Medicinal Chemistry, 2014, Vol. 14, No. 6    13 
The thermal denaturation of ovalbumin, lysozyme, myoglo-
bin and fibrinogen at different 3-(2-Benzothiazolylthio)-
propanesulfonic acid (BTS)concentrations have been inves-
tigated using DSC. The thermal denaturation of the four pro-
teins was completely irreversible. A major effect is observed 
in the case of myoglobin, the protein with the highest -
helical secondary structure (75%). This could be related with 
the fact that backbone hydrogen bonds of -helix are gener-
ally slightly weaker than those found in -sheets. Thus, they 
are readily attacked by the surrounding BTS molecules 
[102]. 
The complex formed due to the interaction of the am-
phiphilic betablocker acebutolol with fibrinogen in a buffer 
solution (50mN glycine, pH of 8.5) was investigated. The 
transitions from the native to the unfolded state of fibrinogen 
induced by acebutolol have been found to be a multiple step 
process with intermediate molten globule states [103]. 
Isothermal Titration Calorimetry [104] experiments show 
that the interaction of cytochrome c with ferulic acid is 
driven by a moderately favorable entropy increase in combi-
nation with a less favorable enthalpy decrease for the first 
binding site of the protein [105]. The interaction energies of 
the NimA protein and the antibiotics: metronidazole, tinida-
zole, ornidazole and dimetrazoleantibiotic were are studied 
by ITC. Measurements found that one NimA dimer has two 
antibiotic binding sites which were not affected by mutation. 
The enthalpy release upon binding to NimA for the four 
drugs studied was relatively low, because of the drug binding 
is mainly entropy driven and along with the hydrophobic 
drug binding site [106]. Evaluation of binding of vismodebig 
(a selective Hedgehog pathway inhibitor) with human and rat 
AAGs and albumins have confirmed that binding is rapidly 
and completely reversible. The data suggest that as com-
pound enters the bloodstream, it will preferentially bind to 
available binding sites on AAG rather than albumin [107]. 
ITC studies further demonstrate that quinacrine can serve as 
a targeting ligand for specific delivery of additional thera-
peutic molecules or imaging agents to the receptor-
overexpressing cancer cells implicated in breast and prostate 
cancers. Pertinent to this targeting utility, it would be possi-
ble to apply the concept of multivalent ligand design, in 
which even suboptimal targeting capability can be enhanced 
through multivalent tight binding [108]. 
6. SUMMARY AND OUTLOOKS 
In summary, we have highlighted the advances in drug 
self-assemblies and discuss in detail their synthesis, physical 
properties and applications as well as their interaction with 
proteins. We also examine, evaluate and link various bio-
informatics procedures applied to drug self-assembly and it 
interaction with biological units. Bio-informatic strategies 
are new tools to link the biological networks with specific 
units relevant to clinical disease, facilitating the integration 
of experimental data with sophisticated statistical ap-
proaches. The examples discussed clearly underline the sig-
nificant advances made on the compression of drug self-
assembly and it application in medicinal chemistry. Even 
though the vast effort made on the bio-inspired supramolecu-
lar self-assembly topic, we believe that more work needs to 
be dedicated to incorporate the information related to the 
drugs colloidal aggregation in the following areas: (i) smart 
biomaterials development; (ii) synthesis of naturally mimick-
ing hierarchical self-assemblies structures; (iii) incorporation 
of bio-functional segments to improve the biofunctionality 
and bioactivity of bio- medical devices.  
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